These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5717215)

  • 21. Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide.
    Moore J; Englert H; Furlong T; Poon T; Milliken S; Ma D
    Bone Marrow Transplant; 2012 Nov; 47(11):1486-7. PubMed ID: 22522570
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cortisone-induced myopathy].
    Federico P; Telesco R; Varriale A; Guarino V; Sasso M; De Rosa G
    Rass Int Clin Ter; 1971 Apr; 51(7):385-99. PubMed ID: 5088118
    [No Abstract]   [Full Text] [Related]  

  • 23. [American histoplasmosis: a case with cutaneous presentation in Morocco].
    Chihab W; Achergui A; Agoumi A; Chraïbi H; Hassam B; Mansouri F
    Med Trop (Mars); 2003; 63(2):171-4. PubMed ID: 12910657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood uric acid in non-gouty subjects undergoing chronic corticoid therapy].
    Secondo G; Roque Molina M
    Reumatismo; 1967; 19(3):204-7. PubMed ID: 5609356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of chronic rheumatoid arthritis. 6. Immunosuppression therapy in chronic rheumatoid arthritis, with special reference to the treatment with cyclophosphamide].
    Takasugi K
    Ryumachi; 1973 Oct; 13(4):374-6. PubMed ID: 4802715
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Brooks PM
    Arthritis Rheum; 1999 Nov; 42(11):2286-92. PubMed ID: 10555022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of rheumatoid arthritis with cyclophosphamide (Endoxan)].
    Jarlov NV; Sorensen K
    Ugeskr Laeger; 1971 Apr; 133(13):587-9. PubMed ID: 5554491
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more effective than G-CSF alone in mobilizing hemopoietic progenitor cells in severe, refractory rheumatoid arthritis.
    Caporali R; Perotti C; Pedrazzoli P; Da Prada GA; Bernuzzi S; Montecucco C
    Haematologica; 2001 Jan; 86(1):106-7. PubMed ID: 11146583
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.
    Valentini G; Paone C; La Montagna G; Chiarolanza I; Menegozzo M; Colutta E; Ruocco L
    Scand J Rheumatol; 2006; 35(1):35-8. PubMed ID: 16467039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome?
    Hirohata S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):358-9. PubMed ID: 16932719
    [No Abstract]   [Full Text] [Related]  

  • 32. Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma).
    Tolchin SF; Winkelstein A; Rodnan GP; Pan SF; Nankin HR
    Arthritis Rheum; 1974; 17(4):375-82. PubMed ID: 4851019
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide pulse in combination therapy for refractory rheumatoid arthritis.
    Maeyaert B; Westhovens R; Dequeker J
    J Rheumatol; 1996 Jan; 23(1):197-8. PubMed ID: 8838540
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
    Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
    J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On griseofulvin therapy of primary chronic polyarthritis].
    Urbaszek W; Luschnitz E
    Z Rheumaforsch; 1965 Dec; 24(11):416-9. PubMed ID: 5869790
    [No Abstract]   [Full Text] [Related]  

  • 40. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.